InVivo Therapeutics has announced three new sites have been added to the company’s ongoing pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI):
- Keck Hospital of University of Southern California (USC) in Los Angeles, CA
- UC Davis Medical Center in Sacramento, CA
- University of Kansas Medical Center in Kansas City, KS
For more information, please visit the company’s ClinicalTrials.gov registration site: